Lumida
/IR
⌘K
Ingersoll Rand Inc

Ingersoll Rand Inc

IR
$72.93USD↓-0.22%-0.16 today

MARKET CAP

28.3B

P/E (TTM)

49.3x

FWD P/E

—

DAY RANGE

$72 – $75

52W RANGE

$68
$101

AI Summary

Stalk
TrimMedium

IR remains entrenched in a medium-term downtrend under declining EMAs, with an active Lower Highs & Lower Lows pattern indicating persistent selling pressure. Price is extended below the EMA9–EMA20 zone with muted bounce volume and extreme oversold RSI, suggesting timing is unfavorable for selling now. Optimal sell-side entries should be deferred until a relief rally into the 75.00–77.40 resistance area (EMA9–EMA20) offers a valid rejection setup.

  • ↑Q2 2026 revenue $2B (+8% YoY) and adjusted EPS $0.86 (+7%)
  • ↑Free cash flow $269M (+28% YoY) funding $248M in share buybacks
  • ↓Adjusted EBITDA margin 25.4% pressured by tariffs and volume declines
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Ingersoll Rand Inc. (NYSE: IR) is a leading global manufacturer of industrial equipment, specializing in air compression, fluid handling, and power tools across diverse sectors such as life sciences and clean energy. The company is recognized for its commitment to sustainability and innovative solutions, which positions it favorably within the ongoing transition towards energy efficiency. Ingersoll Rand is well-regarded in the industry for its strategic approach to mergers and acquisitions (M&A), enabling it to enhance product offerings and bolster market presence.

Bull says

  • ↑Q2 2026 revenue $2B (+8% YoY) and adjusted EPS $0.86 (+7%)
  • ↑Free cash flow $269M (+28% YoY) funding $248M in share buybacks
  • ↑16 acquisitions in 2025 added ~$275M annual revenue
  • ↑Recurring revenue tops $450M with backlog of ~$1.1B
  • ↑Positive earnings yield and strong profitability support valuation
  • ↑Focus on energy efficiency and biopharma drives future growth

Bear says

  • ↓Adjusted EBITDA margin 25.4% pressured by tariffs and volume declines
  • ↓Geopolitical tensions delay long-cycle orders, capping near-term growth
  • ↓Short-cycle demand volatility points to low single-digit Q1 2026 growth
  • ↓Competitive pricing pressure and elevated short interest heighten risks
  • ↓Aggressive M&A pace raises integration risk and potential dilution
  • ↓Reliance on organic recovery amid inflation and tariff uncertainty

Investment themes with IR

SPY↑ +0.09%

NVDA · AAPL · GOOGL

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-18-2026neutral

Transcript signals

Bull points

  • orders continued their strong start of 8% year-over-year with the book-to-bill of 1.03 times.
  • We are pleased with the first half organic order performance, which is up low single digits.
  • free cash flow for the second quarter was $210 million, which was down year over year due primarily to the timing of bond interest payments. Year to date, free cash flow remains robust, up 13% year over year.

Bear points

  • The year-over-year decline in adjusted EBITDA margin was driven primarily by the flow-through on organic volume declines, as expected, the dilutive impact from recently acquired businesses, the dilutive impact of tariff pricing matching tariff costs one-for-one, and continued targeted investments to drive organic growth.
  • we recorded both the non-cash goodwill and asset impairment.
  • the orders here got a bit worse, turned negative again.
Read full transcript analysis ›